Skip to content

Self-Collection for Cervical Cancer Screening and HPV Vaccination for Cancer Prevention Among Women in Emergency Care in Northeast Florida

Eligibility and Participation Characteristics of a Pilot Study of Self-Collection for Cervical Cancer Screening and HPV Vaccination for Cancer Prevention

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06607874
Enrollment
100
Registered
2024-09-23
Start date
2027-09-16
Completion date
2028-10-16
Last updated
2026-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human Papillomavirus-Related Cervical Carcinoma

Brief summary

Human Papilloma Virus (HPV) is a cause of cervical cancer in women. This study is being done to identify sites for cervical cancer screening and education regarding HPV vaccination outside of the traditional settings of primary care and gynecologic clinics. Identifying non-traditional cancer screening settings may increase cancer screening completion and HPV vaccination among women with limited health care knowledge and access who are vulnerable to health disparities.

Interventions

OTHERNon-Interventional Study

Non-Interventional study

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Adults assigned as female at birth age 18-65 with a Mayo Clinic medical record number

Exclusion criteria

* Adults assigned as female at birth age 0-17 * Adults assigned as female at birth age \> 65 * Adults assigned as male at birth * Adults assigned as female at birth without a Mayo Clinic medical record number

Design outcomes

Primary

MeasureTime frameDescription
Human Papilloma Virus (HPV) sample self-collection following Emergency Department (ED) presentationBaselineWill be assessed by the percentage of women between 25-65 eligible for cervical cancer screening who participate or who opt not to participate in self-collection.
HPV vaccination following ED presentationOne monthWill be assessed by the percentage of women between 18-26 eligible for HPV vaccination for cervical cancer prevention who participate in HPV vaccination. Participants will be contacted one month after initial contact to determine if the HPV vaccination was administered.
Interviews of women who decline self-collectionBaselinePhone or video-based interviews will be conducted with eligible participants who decline self-collection to determine reasons for non-participation.
Interviews of women who consent to self-collection but do not complete the self-collectionUp to 6 weeksPhone or video-based interviews will be conducted with participants who agree to participate but do not complete self-collection after 4 weeks to determine reasons for non-participation.
Interviews of women who complete the self-collectionUp to 6 weeksPhone or video-based interviews will be conducted with participants who completed self-collection for feedback on the process.

Countries

United States

Contacts

CONTACTClinical Trials Referral Office
mayocliniccancerstudies@mayo.edu855-776-0015
CONTACTCaroline Chang
Chang.Caroline@mayo.edu904-953-4637
PRINCIPAL_INVESTIGATORChristopher C. DeStephano, MD, MPH

Mayo Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 6, 2026